cbdMD completes 1-for-45 reverse stock split effective April 24, 2023

cbdMD, Inc.

Reverse split ratio of 1:45 effective 12:01 a.m. ET on April 24, 2023, as approved by shareholders on Feb 16, 2023.
No fractional shares issued; shareholders entitled to fractional share receive one whole share instead.
CUSIP changed to 12482W 309; common stock began trading on split-adjusted basis on NYSE American on April 25, 2023.
Par value and authorized shares unchanged; all options, warrants, and Series A preferred adjusted per terms.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

cbdMD, Inc.: Filed Articles of Amendment to effect a 1-for-45 reverse stock split of common stock (effective 2023-04-24).

Change: charter amendment
Effective: 2023-04-24

Exact text from the filing

On April 24, 2023, cbdMD, Inc. (the “Company”) filed an Articles of Amendment to the Company’s Articles of Incorporation, as amended, with the Secretary of State of the State of North Carolina (the “Articles of Amendment”), which effected, at 12:01 a.m. Eastern Time on April 24, 2023, a one-for-45 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”).

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

cbdMD, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-011231

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.